Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
77.23
-3.04 (-3.79%)
At close: Feb 26, 2026, 4:00 PM EST
77.44
+0.21 (0.27%)
After-hours: Feb 26, 2026, 4:10 PM EST
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.12 billion as of February 26, 2026. Its market cap has increased by 516.79% in one year.
Market Cap
1.12B
Enterprise Value
1.08B
1-Year Change
516.79%
Ranking
Category
Stock Price
$77.23
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.12B, an increase of 466.60%. That is a compound annual growth rate of 170.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 1.17B | 1.61% |
| Dec 31, 2025 | 1.15B | 415.39% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.25B |
| Taysha Gene Therapies | 1.24B |
| Vir Biotechnology | 1.24B |
| Pharming Group | 1.17B |
| uniQure | 1.10B |
| Day One Biopharmaceuticals | 1.09B |
| Phathom Pharmaceuticals | 1.09B |
| Xeris Biopharma Holdings | 1.08B |